Wednesday Talk: Nov. 13, 2024, 10am-12pm – hybrid

Speaker: Yvonne Bombard, IHPME, U of T Institute of Health Policy, Management and Evaluation, U of T

Title: “Delivering Precision Genomic Medicine: Evidence, Policy and Equity”

Genetic testing has become increasingly popular in recent years, as people seek to learn more about their health and ancestry. With advances in technology, it has become easier and more affordable to get genetic testing done. However, there are still many concerns about the potential risks and limitations of genetic testing, such as the possibility of false positive or negative results, and the ethical implications of using genetic information.
Digital health has also become an important area of focus in recent years, as technology has the potential to revolutionize the way healthcare is delivered. Digital health tools, such as health apps and wearable devices, allow patients to track their health data and communicate with healthcare providers more easily. With the use of digital health-enabled genomics, patients can access genetic testing and receive personalized treatment plans based on their genetic information.

Bio: Dr. Yvonne Bombard is a genomics health services researcher and Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Unity Health Toronto. She is an Associate Professor at the Institute of Health Policy, Management and Evaluation at the U of T and directs the Genomics Health Services Research Program at St. Michael’s Hospital. She sets research direction at national and international levels as Board Member of the American Society of Human Genetics and CIHR’s Institute of Genetics. Dr. Bombard advises on funding recommendations on emerging genetic testing technologies for Ontario. She also shapes genomics health services research as an editor for Genetics in Medicine Open, the leading genetics practice journal. Dr. Bombard was the inaugural recipient of the Maurice McGregor Award for Demonstrated Excellence and Leadership Potential from the Canadian Agency for Drugs and Technologies in Health (CADTH) and also received a ‘Rising Star’ award from CIHR’s Institute of Health Services and Policy Research. She has been awarded a CIHR Foundation grant as an Early Career Investigator, CIHR Maud Menten Early Career Prize in Genetics and recently received Canadian Cancer Society’s early career investigator award for her work and policy change.

The link to register is  https://forms.office.com/r/T6SMgdE8hF

The deadline to register is the Monday before the event at noon.  The Zoom link will be sent to registrants only.